mimosine has been researched along with deferoxamine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Z; You, Q; Zhang, X | 1 |
| Abe, T; Akita, T; Kamiya, K; Katoh, S; Kodama, I; Toyama, J | 1 |
| Arthur, HM; Brock, JH; Kontoghiorghes, GJ; Licéaga, J | 1 |
| Brock, JH; Kontoghiorghes, GJ; Licéaga, J | 1 |
| Farinelli, SE; Greene, LA | 1 |
| Kulp, KS; Vulliet, PR | 1 |
| Green, SL; Kulp, KS; Vulliet, PR | 1 |
| Baraban, JM; Hall, D; Lin, KI; Marquis, JC; Miller, MP; O'Donovan, K; Ratan, RR; Ryu, H; Semenza, GL; Zaman, K | 1 |
| Choi, BM; Chung, HT; Kang, CL; Kim, JD; Pae, HO; Yoo, JC | 1 |
| Cook, J | 1 |
| Ju, TC; Yang, DI; Yang, YT | 1 |
| Clemens, TL; Deng, LF; Duvall, CL; Eberhart, A; Gilbert, SR; Guldberg, RE; Mavalli, M; Ramaswamy, G; Shen, X; Wan, C; Wang, Y | 1 |
| Agis, H; Gruber, R; Watzek, G | 1 |
| Agis, H; Cvikl, B; Gruber, R; Müller, HD; Watzek, G | 1 |
| Cao, J; Fan, Y; Gao, L; Han, Z; Li, Y; Song, D; Wang, C; Wang, G; Xu, Z; Yin, Z | 1 |
| Fujita, K; Kainuma, S; Kozawa, O; Kuroyanagi, G; Matsushima-Nishiwaki, R; Ohguchi, R; Otsuka, T; Tokuda, H; Yamamoto, N | 2 |
| Agis, H; Janjić, K; Lilaj, B; Moritz, A | 1 |
| Agis, H; Janjić, K; Kurzmann, C; Moritz, A; Müller, AS; Oberoi, G; Pensch, M | 1 |
| Agis, H; Edelmayer, M; Gashi, M; Janjić, K; Moritz, A; Müller, AS | 1 |
| Espósito, BP; Silva, FT | 1 |
1 review(s) available for mimosine and deferoxamine
| Article | Year |
|---|---|
Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: A perspective.
Topics: Animals; Catalytic Domain; Chelating Agents; Chemistry, Pharmaceutical; Drug Design; Humans; Metalloproteins | 2019 |
20 other study(ies) available for mimosine and deferoxamine
| Article | Year |
|---|---|
Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts.
Topics: Animals; Animals, Newborn; Catechols; Creatine Kinase; Deferoxamine; Electron Spin Resonance Spectroscopy; Free Radicals; Heart; In Vitro Techniques; Iron Chelating Agents; Mimosine; Myocardial Reperfusion Injury; Myocardium; Pyrones; Rabbits; Ventricular Function, Left | 1992 |
Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
Topics: Animals; Deferiprone; Deferoxamine; Iron; Iron Chelating Agents; Iron Radioisotopes; Macrophages; Mice; Mimosine; Pyridones; Pyrones | 1990 |
The effect of synthetic iron chelators on bacterial growth in human serum.
Topics: Bacteria; Deferoxamine; Humans; Iron Chelating Agents; Mimosine; Pyrones | 1988 |
Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support.
Topics: Animals; Aphidicolin; Apoptosis; Cell Cycle; Cell Division; Ciclopirox; Cyclic AMP; Deferoxamine; G1 Phase; Mimosine; Mitosis; Nerve Growth Factors; Neurons; Nocodazole; PC12 Cells; Pyridones; Rats; Superior Cervical Ganglion; Teniposide; Thionucleotides | 1996 |
Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells.
Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cell Survival; Deferoxamine; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Humans; Iron; Mimosine; Proline-Directed Protein Kinases; Protein Serine-Threonine Kinases; Siderophores; Tumor Cells, Cultured | 1996 |
Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells.
Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cell Line; Cyclin D; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Deferoxamine; DNA, Neoplasm; Female; Humans; Iron; Iron Chelating Agents; Kinetics; Mimosine; Proto-Oncogene Proteins; Tumor Cells, Cultured | 1996 |
Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and ery
Topics: Activating Transcription Factor 1; Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Chelating Agents; Cobalt; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Deferoxamine; DNA-Binding Proteins; Enzyme Induction; Erythropoietin; Fetus; Fructose-Bisphosphate Aldolase; Gene Expression Regulation; Glutathione; Glycolysis; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; L-Lactate Dehydrogenase; Mimosine; Neurons; Neuroprotective Agents; Nuclear Proteins; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transcription Factors | 1999 |
Apoptotic cell death induced by taxol is inhibited by nitric oxide in human leukemia HL-60 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Deferoxamine; DNA Fragmentation; G1 Phase; Glutathione; Growth Inhibitors; HL-60 Cells; Humans; Mimosine; Nitric Oxide; Nitroso Compounds; Paclitaxel; S Phase; S-Nitrosoglutathione | 1999 |
Radiation sensitization of mammalian cells by metal chelators.
Topics: Animals; Cell Cycle; Chelating Agents; Colony-Forming Units Assay; Cricetinae; Cricetulus; Deferiprone; Deferoxamine; DNA Replication; Edetic Acid; Fibroblasts; Genes, p53; Humans; Iron Chelating Agents; Lung; Lung Neoplasms; Mimosine; Pyridones; Radiation-Sensitizing Agents; S Phase; Tumor Cells, Cultured | 2001 |
Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells.
Topics: Animals; Astrocytes; Cell Death; Cell Line, Tumor; Cell Survival; Cobalt; Deferoxamine; DNA-Binding Proteins; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mimosine; Nitro Compounds; Nuclear Proteins; Propionates; Rats; Signal Transduction; Transcription Factors | 2005 |
Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice.
Topics: Amino Acids, Dicarboxylic; Animals; Bony Callus; Cell Proliferation; Deferoxamine; Endothelium, Vascular; Femoral Fractures; Hypoxia-Inducible Factor 1; Male; Mice; Mice, Inbred C57BL; Mimosine; Models, Animal; Neovascularization, Physiologic; Procollagen-Proline Dioxygenase; RNA, Messenger; Vascular Endothelial Growth Factor A | 2009 |
Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor by periodontal fibroblasts.
Topics: Amino Acids, Dicarboxylic; Antimutagenic Agents; Cell Proliferation; Cell Survival; Cells, Cultured; Cobalt; Cyclin-Dependent Kinase Inhibitor p27; Deferoxamine; Enzyme Inhibitors; Fibroblasts; Gingiva; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Interleukin-1; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Ki-67 Antigen; Mimosine; p38 Mitogen-Activated Protein Kinases; Periodontal Ligament; Procollagen-Proline Dioxygenase; Protein Kinase Inhibitors; Proteins; Siderophores; Vascular Endothelial Growth Factor A | 2012 |
Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor in dental pulp-derived cells.
Topics: Amino Acids, Dicarboxylic; Cells, Cultured; Cobalt; Deferoxamine; Dental Pulp; Dental Pulp Capping; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mimosine; Neovascularization, Physiologic; Procollagen-Proline Dioxygenase; Regeneration; Siderophores; Vascular Endothelial Growth Factor A | 2012 |
Effect of iron deficiency on c-kit⁺ cardiac stem cells in vitro.
Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Cell Cycle; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Deferoxamine; Flow Cytometry; Heart; In Vitro Techniques; Iron Deficiencies; Mice; Mice, Inbred C57BL; Mimosine; Proto-Oncogene Proteins c-kit; Siderophores; Stem Cells | 2013 |
Mimosine suppresses the PGF2α-induced synthesis of osteoprotegerin but not interleukin-6 in osteoblasts.
Topics: Animals; Cell Differentiation; Cell Line; Deferoxamine; Dinoprost; Gene Expression Regulation, Developmental; Hypoxia-Inducible Factor 1; Interleukin-6; MAP Kinase Kinase 4; Mice; Mimosine; Osteoblasts; Osteoprotegerin; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; RNA, Messenger; Transcription Factors; Tumor Suppressor Protein p53 | 2016 |
Attenuation of prostaglandin E1‑induced osteoprotegerin synthesis in osteoblasts by normoxic HIF inducers.
Topics: Alprostadil; Animals; Cell Line; Deferoxamine; Fabaceae; Hypoxia-Inducible Factor 1; Interleukin-6; MAP Kinase Kinase 4; Mice; Mimosine; Osteoblasts; Osteoprotegerin; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Biosynthesis; RNA, Messenger | 2017 |
Formation of spheroids by dental pulp cells in the presence of hypoxia and hypoxia mimetic agents.
Topics: Chemokine CXCL12; Deferoxamine; Dental Pulp; Enzyme-Linked Immunosorbent Assay; Glycine; Humans; Hypoxia; Interleukin-8; Mimosine; Spheroids, Cellular; Vascular Endothelial Growth Factor A | 2018 |
Deferoxamine but Not Dimethyloxalylglycine, L-Mimosine, or Cobalt Dichloride Can Interfere with the MTT Assay.
Topics: 3T3 Cells; Amino Acids, Dicarboxylic; Animals; Biocompatible Materials; Cell Line; Cell Survival; Cobalt; Deferoxamine; Dimethyl Sulfoxide; Mice; Mimosine; Tetrazolium Salts; Thiazoles | 2018 |
The impact of clay-based hypoxia mimetic hydrogel on human fibroblasts of the periodontal soft tissue.
Topics: Amino Acids, Dicarboxylic; Biocompatible Materials; Cell Hypoxia; Cells, Cultured; Clay; Cobalt; Deferoxamine; Drug Delivery Systems; Fibroblasts; Humans; Hydrogels; Mimosine; Periodontium; Tissue Scaffolds | 2019 |
Intracellular Iron Binding and Antioxidant Activity of Phytochelators.
Topics: Antioxidants; Deferoxamine; Humans; Iron; Iron Chelating Agents; Iron Overload; Mimosine; Pyridones; Tropolone | 2022 |